Navigation Links
Novel imaging approach may assist in predicting success of treatment for atrial fibrillation
Date:10/7/2008

SALT LAKE CITY University of Utah researchers have developed a magnetic resonance imaging (MRI)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation. The results of the study are published in the Oct. 7, 2008, issue of the Journal of the American College of Cardiology.

Atrial fibrillation (AF) is an arrhythmia, or abnormal heart rhythm, that involves the heart's two upper chambers, or atria. One effective method of treating AF is radiofrequency (RF) ablation. In RF ablation, mild, painless radiofrequency energy is used to destroy carefully selected heart muscle cells to stop them from conducting extra electrical impulses. Previous research suggested scar formation within the left atrium (LA) after RF ablation helps to predict the success of the procedure in preventing the recurrence of atrial fibrillation.

"Until now, there has not been an accurate, non-invasive way to assess LA scar formation," said lead author Nassir F. Marrouche, M.D., assistant professor of internal medicine in the University of Utah School of Medicine and director of the Atrial-Fibrillation Program. "We have developed a novel MRI-based method to detect and measure the extent of LA wall scarring and, potentially, predict the success of RF ablation in patients with atrial fibrillation."

MRI is a medical imaging technique that utilizes a powerful magnetic field to create detailed images of the body. In this study, Marrouche and his University of Utah colleagues developed a technique for using a non-invasive method called delayed-enhancement cardiovascular MRI (DE-CMRI) to create 3-D images of the left atrium both before and after RF ablation in patients with atrial fibrillation. They processed and analyzed these images using custom software tools and then used computer algorithms to calculate the extent of LA wall injury.

Marrouche and his co
'/>"/>

Contact: Chantelle Turner
chantelle.turner@hsc.utah.edu
801-581-7387
University of Utah Health Sciences
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NIH Awards a Phase I Small Business Innovative Research Grant on "Novel Laser Scanning Technology for Computed Radiography" to VIXAR and iCRco
2. Novel tuberculosis vaccine in Germany in clinical phase
3. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
4. Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
5. Bruker Daltonics Showcasing Novel Proteomics Solutions Based on Mass Spectrometry at the 7th HUPO World Congress 2008
6. NIH scientists find a novel mechanism that controls the development of autoimmunity
7. Sales of Emerging Novel Pain Therapies Will Represent More than One-Fifth of the Total Pain Drug Market by 2023
8. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
9. Toyota Tsusho America, Inc. and Nippon Kayaku Co., Ltd. Announce the Formation of GlycoMark, Inc., a Joint Venture to Develop and Commercialize Novel Biomarkers for Diabetes
10. Finding suggests novel ways to boost vaccination or natural defenses
11. Novel hydrogel systems for dentin regeneration

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...oyant Health™ announced today that Spectrum ...raumaCad Enterprise orthopedic templating solution... (PRWEB) November 27, 2009 --...m Health (Grand Rapids, Michigan) has licensed its...on and its TraumaCad Extend workflow solution, to ...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)... number of Americans living with diabetes will nea...o 44.1 million in 2034. Over the same period, spen...113 billion to $336 billion, even with no increase...t the University of Chicago report in the December... with diabetes covered by Medicare will rise from ...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...esearch Triangle Dental (RTDental), a leading dent... announced the expansion of its services to includ...oug Macmillan. , Durha...ed to announce that Dr. Doug Macmillan, an experie...ditional advanced training seminar. RTDental&rsqu...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
... has announced the introduction of the routine pne...programme , with a motive to prevent children from... The pneumococcal infection, upon entering the blo...ost to pneumococcal infections in England and Wale...
...a joint venture with a South African company that ...retroviral drugs in Africa. //A joint venture betw...tment Holdings has been signed, that will give aut...pany to make the drugs available at a low cost. ...
...e, Hepatitis C alone infects more than 170 million... which leads to both acute and chronic liver disea...y anti viral therapy to be produced against it the...nd an efficient virus production and infection sys...
... outbreak of foot and mouth disease of cattle, nea...e have been found to show infection signs in the C...onal Service for Food Safety and Quality. T... occurred five years ago in Argentina, World’s lea...
...sease buster might be now challenged. A Univers...more fruits, vegetables and grains had no reduced ...l they were // healthier than others. The dra...ods. As said by Dr. Jeanette Keith of the Uni...
...r University, it has been found that low birth wei... birth weight. // Infact, they have been found to ...joy similar levels of independence as their counte...udies have established that low birth weight infan...
Other Medicine News:Health News:Pneumococcal Vaccine: Childhood Immunization Programme has a new recruit 2Health News:Florida State University declares a breathtaking study which might solve the Hepatitis C Virus maze and find a cure! 2Health News:Fat isn't all that bad: Reduction no predecessor of reduced disease 2Health News:Premature Babies Give It Their Best Shot To Overcome Difficulty 2
(Date:11/25/2009)...N, N.J., Nov. 25 Pharmas...aceutical company committed to discovering, develo...l infections, reported financial results for the f...30, 2009 Pharmasset held $58.4 million in cash, ca... Pipeline Update and 2009 Highlights ,, RG712...
(Date:11/25/2009)...R, N.J., Nov. 25 The FDA granted t...e) tablets, a non-nucleoside reverse transcriptase...ecifically indicated for use in treatment-experien...with HIV-1 strains resistant to an NNRTI and other...roval is based on 48-week data from two Phase 3 st...
(Date:11/25/2009)...RIDGE, N.J., Nov. 25 Regado Biosci...pment of antithrombotic aptamers with active contr...d President, will be presenting at the Piper Jaffr...ork Palace Hotel in New York City. Dr. Mazzo,s pr...y, December 1 and will include an overview of the ...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Misuse of antibiotics not the only cause of resistance says report 10386 1Misuse of antibiotics not the only cause of resistance says report 10386 2Department of Public Welfare Earns Federal Recognition for Programs and Services for Children 59573 1Department of Public Welfare Earns Federal Recognition for Programs and Services for Children 59573 2Donor Sperm Providers Form New Non Profit 59569 1
...d with QT Prolongation- -Favorable Cardi... 19 Advanced Life Sciences,Holdings, Inc. (Nasdaq...rial,CL07-001, a thorough QT study of the Company,...his study was conducted to evaluate the cardiac,sa...base for the Company,s,upcoming New Drug Applicati...
...scientific,publications strategy, planning and del...guidelines. Half of global publications groups are...ications leaders foresee a shift,to medical groups... new,report released by Best Practices, LLC., In ...l companies as,Pfizer, GlaxoSmithKline, Lilly and ...
Other Medicine Technology:Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 2Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 3Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 4Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 5Advanced Life Sciences Announces Successful Thorough QT Study of Cethromycin 6Industry Executives Finding Value in Shift of Scientific Publications 2
IMMULITE/IMMULITE 1000 IGFBP-3
...ction of Anti-Nuclear Antibodies (ANAs) has long b... rheumatic diseases. The antigens used in their de...uman or animal nuclei, this has led to them being ...st commonly measured ENA specifications are anti-S...
...nostic Automation, Inc. (DAI) ENA Profile Enzyme-L...the detection of antibodies in human serum to indi...), Scl-70 and Jo-1 in a single serum specimen. The...the diagnosis of systemic lupus erythematosus (SLE...
Sm/RNP Anti-Extractable Nuclear Antigen (ENA) Antibodies Kit
Medicine Products: